Tuberculosis News and Research

Latest Tuberculosis News and Research

Tamir's compounds perform better than Ganciclovir for Cytomegalovirus disease: Study

Tamir Biotechnology, Inc. announced today that scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) reported test results confirming two of our lead compounds outperformed market leader Roche's drug Ganciclovir in cell culture and plaque reduction assay (the gold standard) for Cytomegalovirus (CMV) disease. Additionally, antiviral activity was also apparent against other human herpesviruses, namely, HSV-1 (cold sores), HSV-2 (genital herpes), and Varicella-Zoster Virus (VZV) (chicken-pox and shingles).

29 Sep 2010

NIH grants Akonni $3M for development of multi-drug resistant/extensively drug-resistant genotyping test

Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated genetic testing devices for complex infectious and human diseases, today announced receipt of a nearly $3 million Challenge Grant from the National Institutes of Health (NIH), a new program made possible under the American Recovery and Reinvestment Act (ARRA).

29 Sep 2010

Computer simulations show low prevalence of TB increases MDR-TB risk

While the U.S. has made great progress in the prevention and treatment of tuberculosis, the nation has become more susceptible to potential epidemics of multidrug-resistant tuberculosis (MDR-TB), according a study led by Johns Hopkins researchers. Computer simulations show that as TB prevalence falls, the risk for more extensive MDR-TB increases.

28 Sep 2010

NPL, Orla receives fund to improve detection methods for TB

Two UK companies have been awarded joint funding for a research project that could see significant advances in the quest to aid detection and eradication of Tuberculosis (TB), across the world.

28 Sep 2010

Opinions: U.S. food aid; MDGs; Contraceptive access, technology; U.S. AIDS funding; Foreign assistance reform

"The best way to help the millions of hungry people in countries that receive food aid get rid of their corrupt and incompetent rulers - and to ensure that their children will never go hungry in future — is to starve them now. That will turn them into raging, unstoppable anti-government regime changers," writes Nation Media Group Executive Editor Charles Onyango-Obbo in an East African opinion piece.

28 Sep 2010

MDG summit: Funding the Global Fund; Arab world's 'own challenges'

BusinessDay reports that following last week's Millennium Development Goal summit at the U.N. in New York, advocates "have called on rich nations to double their pledges to the Global Fund to Fight AIDS, Tuberculosis and Malaria, saying it desperately needs more money if the world is to meet the health-related Millennium Development Goals by 2015."

28 Sep 2010

BMC physicians receive $3M NIH grant to identify TB biomarkers

Boston Medical Center has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis. Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine, a renowned expert in the field, will serve as principal investigator on the five-year, $3 million grant funded by the National Institutes of Health.

28 Sep 2010

BMC physicians to lead international research collaboration to curb infectious diseases

Boston Medical Center (BMC) has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis (TB). Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine (BUSM), a renowned expert in the field, will serve as principal investigator (PI) on the five-year, $3 million grant funded by the National Institutes of Health (NIH).

27 Sep 2010

Global leaders announce new commitments to accelerate progress towards ending malaria deaths

Prominent leaders in global health and development joined several African heads of state at UN Headquarters today to announce new commitments to accelerate progress toward ending deaths from malaria, a disease that claims the lives of more than 850,000 Africans each year.

24 Sep 2010

CGI summit looks at businesses' involvement in philanthropy

A growing number of companies are putting more emphasis on philanthropic investments, former President Bill Clinton and business leaders said on Wednesday during the second day of the Clinton Global Initiative (CGI) meeting in New York, Reuters reports.

24 Sep 2010

Past exposure to pathogens leads to disease resistance spreading through populations

A study by researchers at Royal Holloway, University of London, University College London and Oxford University, has found that a genetic variant which reduces the chance of contracting diseases such as tuberculosis and leprosy is more prevalent in populations with long histories of urban living.

24 Sep 2010

Researchers discover molecular signature to predict TB infection

Dallas scientists recently discovered a molecular signature in the blood of patients with tuberculosis (TB) that may explain why some people develop an active TB infection, while others exposed to the bacteria which causes the dangerous respiratory virus do not.

24 Sep 2010

ASTMH recommends FDA to include neglected infections of poverty in orphan classification

Today, U.S. scientists committed to finding answers to reducing and eliminating what are known as neglected tropical diseases (NTDs) that plague the world's poorest people in developing countries, urged the FDA to include in its orphan classification the neglected infections of poverty that also affect Americans, and expressed support for stronger relationships with the FDA to ultimately halt these ancient scourges.

24 Sep 2010

AJMS journal provides research update on new infectious pathogens

Newly recognized disease-causing viruses, bacteria, and other infections are continually emerging around the world, posing difficult challenges for patient diagnosis and treatment and for public health responses. A special symposium section of the September issue of The American Journal of the Medical Sciences (AJMS), official journal of the Southern Society for Clinical Investigation, provides a research update on important new infectious pathogens.

24 Sep 2010

World leaders address country ownership, accountability, women at MDG summit

At the U.N. Summit on the Millennium Development Goals (MDGs) on Tuesday African leaders said "they could do more to meet U.N. goals to slash extreme poverty and urged stronger leadership among developing countries to tackle hunger and disease and attract investment," Reuters reports in an article that examines the leaders' call for African nations to take greater ownership over their development.

23 Sep 2010

Opinions: Genetically-modified crops can improve vaccines; MDG focus on women and girls; U.S. leadership for MDGs; Boosting access to drugs; Merits of bilateral development assistance

"The U.N. estimates that diarrheal diseases kill 1.8 million people every year. … So you might take it as good news that American company Ventria Bioscience says it has hit on an improvement to existing rehydration therapies, which could mean another tool in the fight against diarrhea," according to a Wall Street Journal editorial examining the delays the company has experienced since it first sought to have its product approved by the FDA back in 2004, even "[a]fter a panel of food, medicine, immunology, child nutrition and health experts had declared its product safe."

23 Sep 2010

Aeras Global TB Vaccine Foundation to initiate clinical trial of new investigational vaccine

At an international gathering of TB vaccine researchers in Tallinn today, the Aeras Global TB Vaccine Foundation announced it will initiate a clinical trial of an investigational live recombinant tuberculosis vaccine to be led by researchers at Saint Louis University in St. Louis, Missouri, USA. The announcement was made at the Second Global Forum on TB Vaccine Development.

23 Sep 2010

Lilly's multidrug-resistant tuberculosis initiative honored with World Business and Development Award

An eminent international panel of judges has selected Eli Lilly and Company to receive a World Business and Development Award for demonstrating what can be achieved through successful partnerships in the battle against multidrug-resistant tuberculosis (MDR-TB).

22 Sep 2010

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

22 Sep 2010

Secretary-General opens U.N. summit on MDGS with appeal for world leaders to maintain target commitments

On the first of the three-day U.N. Summit on the Millennium Development Goals (MDGs), U.N. Secretary-General Ban Ki-moon on Monday appealed "to the assembled presidents, prime ministers and kings to use their power to meet U.N. goals to help the world's poorest by 2015," the Associated Press reports.

22 Sep 2010

Tuberculosis News and Research

Latest Tuberculosis News and Research

Tamir's compounds perform better than Ganciclovir for Cytomegalovirus disease: Study

NIH grants Akonni $3M for development of multi-drug resistant/extensively drug-resistant genotyping test

Computer simulations show low prevalence of TB increases MDR-TB risk

NPL, Orla receives fund to improve detection methods for TB

Opinions: U.S. food aid; MDGs; Contraceptive access, technology; U.S. AIDS funding; Foreign assistance reform

MDG summit: Funding the Global Fund; Arab world's 'own challenges'

BMC physicians receive $3M NIH grant to identify TB biomarkers

BMC physicians to lead international research collaboration to curb infectious diseases

Global leaders announce new commitments to accelerate progress towards ending malaria deaths

CGI summit looks at businesses' involvement in philanthropy

Past exposure to pathogens leads to disease resistance spreading through populations

Researchers discover molecular signature to predict TB infection

ASTMH recommends FDA to include neglected infections of poverty in orphan classification

AJMS journal provides research update on new infectious pathogens

World leaders address country ownership, accountability, women at MDG summit

Opinions: Genetically-modified crops can improve vaccines; MDG focus on women and girls; U.S. leadership for MDGs; Boosting access to drugs; Merits of bilateral development assistance

Aeras Global TB Vaccine Foundation to initiate clinical trial of new investigational vaccine

Lilly's multidrug-resistant tuberculosis initiative honored with World Business and Development Award

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Secretary-General opens U.N. summit on MDGS with appeal for world leaders to maintain target commitments

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Tuberculosis News and Research

Latest Tuberculosis News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in